KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Amortization of Deferred Charges (2018 - 2020)

Castle Biosciences' Amortization of Deferred Charges history spans 3 years, with the latest figure at $173000.0 for Q4 2020.

  • On a quarterly basis, Amortization of Deferred Charges fell 26.07% to $173000.0 in Q4 2020 year-over-year; TTM through Sep 2021 was $173000.0, a 80.78% decrease, with the full-year FY2020 number at $839000.0, down 56.42% from a year prior.
  • Amortization of Deferred Charges hit $173000.0 in Q4 2020 for Castle Biosciences, down from $214000.0 in the prior quarter.
  • Over the last five years, Amortization of Deferred Charges for CSTL hit a ceiling of $767000.0 in Q2 2019 and a floor of $139273.0 in Q3 2018.
  • Historically, Amortization of Deferred Charges has averaged $269820.2 across 3 years, with a median of $226000.0 in 2020.
  • Biggest five-year swings in Amortization of Deferred Charges: surged 75.91% in 2019 and later tumbled 70.27% in 2020.
  • Tracing CSTL's Amortization of Deferred Charges over 3 years: stood at $139929.0 in 2018, then skyrocketed by 67.23% to $234000.0 in 2019, then fell by 26.07% to $173000.0 in 2020.
  • Business Quant data shows Amortization of Deferred Charges for CSTL at $173000.0 in Q4 2020, $214000.0 in Q3 2020, and $228000.0 in Q2 2020.